Alfred Research Alliance Student Information Night: 11 Aug 2020

The Alfred Research Alliance partners, Monash University's Central Clinical School and School of Public Health and Preventive Medicine, and the major research institutes of Burnet and Baker, are hosting an information evening on Tuesday 11 Aug for people interested in undertaking Honours and graduate research study in 2021 at the Alfred site. We have an amazing line-up of speakers (see program), and see event details below.

Antiviral study for COVID-19 patients seeking participants

Dr James McMahon is leading a study to find out whether an

antiviral called favipiravir will help people with COVID-19

clear the virus from their systems faster. Video explainer

Researchers from The Alfred and Monash University have set out to determine whether an antiviral medication that has been previously studied in people with influenza and other viral infections will help people with COVID-19 recover faster.

Lead researcher and Infectious Diseases specialist Dr James McMahon said the antiviral, Favipiravir, is being studied in multiple countries including the United States and Japan, where it was first developed to treat people with influenza. It is being studied in a number of trials globally to see if it could help clear the COVID-19 virus faster.

How Multiple Sclerosis changes the brain's venous rhythms

Dr Scott Kolbe is lead author on the study which has found that
venous rhythms are changed in people with MS. Video explainer

Monash researchers have discovered both a unique signal within the brain's veins and how Multiple Sclerosis (MS) changes that venous rhythm.

The veins are poorly studied in comparison to the brain's arteries because it is arterial blood flow that is critical for providing oxygen to the brain and occlusion of these vessels leads to stroke. Therefore, it is not well understood how blood travels through the brain's veins on its way back to the heart.

7-20 July 2020 Central Clinical School recent publications

Multiple Sclerosis researchers have published a study on how

social media could help with the rapid dissemination of 

clinically relevant information to patient groups: #MSCOVID19

Recent publications as notified by PubMed during the fortnight 7-20 July 2020 from Central Clinical School affiliated researchers in the following departments. This is not a comprehensive list:

• Allergy, Immunology and Respiratory medicine (AIRmed)
• Anaesthesiology & Perioperative Medicine (APOM)
• Australian Centre for Blood Diseases (ACBD)
• Infectious Diseases
• Medicine - Peninsula
• Melbourne Sexual Health Centre (MSHC)
• Neuroscience
• Surgery and National Trauma Research Institute (NTRI)

Women in Leadership Program 2020: MCHRI Course

Women in Leadership Program 2020

The purpose of this three-day program is to inspire, encourage and support Women in Healthcare and Research to reach their full career potential. 

October 21^st, 22^nd and 23^rd 2020 (Click here to register)

December 15^th, 16^th and 17^th 2020 (Click here to register)

Delivered by Ms. Tracey Ezard who is a Certified E Virtual Presenter, and Professor Helena Teede with support from current leaders in healthcare and research, we will discuss the self-awareness, self-care, mindset and behaviours that create the leadership that is needed in the global context we live and work in.

• We aim to inspire, encourage and support women in healthcare and research to reach their full career potential.
• By providing supportive networks and partnerships, we will explore equal opportunity, capacity, capability building and career strategic planning.
• Tapping into the knowledge of our mentors in the room we will identify areas of growth and development for ourselves and how to support our career goals.

Monash Partners Member Organisation Employees: $ 950

Non-Monash Partners Member Organisation Employees: $ 1250

For more details contact mchri.shortcourses@monash.edu 

12 August event: From the Frontline: Clinical Impacts of COVID-19

Monash’s Medicine, Nursing and Health Sciences proudly presents From the Frontline: Clinical Impacts of COVID-19.

In this free online event, we’ll explore the impact COVID-19 has had on healthcare and what the ‘new normal’ will look like post-pandemic.

Hear from our panel of experts (Prof Jane Fisher, A/Prof Julian Elliott, Prof Merlin Thomas and A/Prof Anneke van der Walt) who are leading clinician-researchers based on the frontline of our hospitals and research facilities. They’ll discuss their COVID-19 research, focus areas, and how these will impact our community.

Event Details

Date: 12 August 2020 at 6:00 pm – 7:30 pm
Campus: Online
Register: https://fromthefrontline.eventbrite.com.au
Categories: Public Health and Preventive Medicine; Clinical Sciences - The Alfred

New drug blocks formation of killer clots to prevent strokes and heart attacks

Four of the co-authors on the paper, L-R: Ms Natasha Setiabakti,
Associate Professor Justin Hamilton,(senior author)
Ms Nurul Aisha Zainal Abidin, Dr Mitch Moon

Monash researchers have found a potential drug that can be given as a preventive against heart attack.

The drug – which has been studied in human cells and animal models – literally blocks the minute changes in blood flow that precede a heart attack and acts on the platelets preventing the platelet-triggered clot from forming before it can kill or cause damage.

One-third of all deaths globally – 18 million a year - are caused by cardiovascular disease, largely heart attack or stroke, both of which are triggered by clots blocking the vessels in the brain or heart.